Significant Ownership of Vivo Capital VIII, LLC

Signature - Title
/s/ Dr. Frank Kung - Dr. Frank Kung, Managing Member
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Vivo Capital VIII, LLC.

Notify me when Vivo Capital VIII, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Vivo Capital VIII, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SVA Sinovac Biotech Ltd. Common Shares, $0.001 par value per share 6.3% 4,541,764 0% Vivo Capital IX, LLC 11 Jul 2025

Schedules 13D/G Reported by Vivo Capital VIII, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.